Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
基本信息
- 批准号:9977714
- 负责人:
- 金额:$ 30.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAfrican AmericanAutomobile DrivingBehaviorBenzo(a)pyreneBindingBiochemicalBioenergeticsBiologicalBiological AssayBiopsyBreastBreast Cancer CellBreast Cancer ModelBreast Cancer PatientBreast Cancer Risk FactorBreast Cancer cell lineCarcinomaCell NucleusCell physiologyCellsChIP-seqClinicalClinical DataCommunitiesComplexComputer AnalysisDNADNA BindingDataData AnalysesDietDrug resistanceDyslipidemiasEndocytosisEnvironmentEnvironmental Risk FactorEthnic OriginEthnic groupFatty acid glycerol estersFutureGene ExpressionGenerationsGenetic PolymorphismHepaticHepatocyteHigh Fat DietHomeostasisHydrophobicityIn VitroInflammationInflammation MediatorsIngestionInsulinIntercellular JunctionsKnowledgeLeadLeptinLightLinkLipidsLipolysisLipoprotein ReceptorLipoproteinsLow incomeLuciferasesMalignant NeoplasmsMammary Gland ParenchymaMeasuresMediatingMembraneMetabolicMolecularNeoplasm MetastasisNuclearObesityOutcomePathologyPathway interactionsPatient-Focused OutcomesPatientsPhenotypePhysiologicalPhysiologyPopulationPostmenopausePrimary NeoplasmProteinsProteomicsROCK1 geneReceptor SignalingRegulationReportingResearchResistanceRisk FactorsRoleSignal TransductionTestingThe Cancer Genome AtlasThinnessTight JunctionsTissuesToxic Environmental SubstancesVery low density lipoproteinWomanXenograft Modelbioaccumulationbreast cancer progressioncancer cellcancer health disparitycancer riskcancer stem cellcancer subtypescell behaviordiet and cancerextracellularhealth disparityin vitro Assayin vivoinsightmalignant breast neoplasmmammary epitheliummigrationmortalitymouse modelneoplastic cellnew therapeutic targetnovelobesogenicoutcome forecastoverexpressionpollutantpromoterprotein functionreceptor expressionreceptor functionresponsesocialsocioeconomicsstem-like cellsugartoxicanttranscriptometumortumor growthtumor initiationtumorigenesisuptakewhole genome
项目摘要
Abstract
This proposal addresses the relationship between African American (AA) and basal-like breast cancers,
obesity, and environmental factors through a novel metabolically-regulated pathway that we have recently
shown drives aggressive tumor cell behaviors. Combining in vitro studies with patient biopsy data and
computational analyses, we will characterize the regulation and function of the widely expressed lipolysis
stimulated lipoprotein receptor (LSR) in normal and transformed breast cells and tissue. LSR is a
multifunctional protein known to mediate the endocytosis of lipoproteins and hydrophobic environmental
toxicants such as benzo[α]pyrene in hepatocytes. Intriguingly, LSR is enriched at cell junctions and we are the
first to show LSR is frequently translocated to the cell nucleus of non-surviving breast cancer (BrCa) patients.
The function and underlying molecular mechanisms for these observations are unknown. Of note, studies
show bodily accumulation of toxicants obtained through the diet promotes obesity and inflammation, and
toxicant bioaccumulation higher in AAs and in low-income communities. Thus, we hypothesize that LSR
expression and/or activity enhances aggressive BrCa phenotypes via modulation of cellular bioenergetics,
toxicant bioaccumulation, and altered signal transduction and transcriptome regulation, thereby contributing to
cancer disparities and poor patient outcome. In support, we recently demonstrated that LSR increases BrCa
proliferation and migration, and enhances cancer stem cell-like and chemotherapeutic resistance features.
Overexpression of LSR in a claudin-low BrCa cell line restores expression of genes involved in transformation,
tumorigenesis, and tight junctions, thereby reverting these cells to other BrCa subtypes. Our pilot data show
high LSR levels are significantly correlated with basal-like tumors, AA ethnicity, and diet-induced obesity. Our
preliminary data also demonstrate that membrane-localized LSR mediates lipid endocytosis, thereby shifting
cellular bioenergetics, while nuclear LSR binds DNA and was significantly associated with patient mortality in a
pilot set of BrCa biopsies. To advance these preliminary studies we propose a dual approach, which includes
delineating LSR's role in driving aggressive BrCa behaviors together with defining the molecular mechanisms
of toxicant uptake and promotion inflammation in breast tissue. Specifically, we aims to (1) identify the LSR-
driven pathways exploited during BrCa progression and the generation of aggressive cell behaviors, and (2)
define the mechanisms of LSR-mediated lipid and toxicant uptake in BrCa cells, and the resultant effects on
cancer bioenergetics and cell physiology. Our proposal may shed light on LSR as a biological link between
obesity, inflammation, cancer disparities, and BrCa physiology. Novel knowledge obtained from the proposed
studies will provide critical insight into the biological basis of dietary influences on breast cancer and may
identify the LSR as a novel therapeutic target.
抽象的
该建议涉及非裔美国人(AA)和类似基本的乳腺癌之间的关系,
肥胖和环境因素通过我们最近有新型的代谢调节途径
显示的驱动侵袭性肿瘤细胞行为。将体外研究与患者活检数据和
计算分析,我们将表征广泛表达的脂解的调节和功能
在正常和转化的乳腺细胞和组织中刺激的脂蛋白受体(LSR)。 LSR是一个
多功能蛋白已知可介导脂蛋白和疏水环境的内吞作用
肝细胞中的有毒物质,例如苯并[α] pyr。有趣的是,LSR在细胞连接处富含,我们是
首先显示LSR经常被转移到非残疾乳腺癌(BRCA)患者的细胞核。
这些观察结果的功能和基本分子机制尚不清楚。值得注意的是,研究
显示通过饮食获得的毒物的身体积累可促进肥胖和感染,并
在AA和低收入社区中,有毒的生物积累较高。那我们假设LSR
表达和/或活性通过调节细胞生物能学,增强了侵略性的BRCA表型,
有毒的生物蓄积,并改变了信号转导和转录组调节,从而有助于
癌症分布和患者效果不佳。为了支持,我们最近证明了LSR增加了BRCA
增殖和迁移,并增强癌症干细胞样和化学治疗性抗性特征。
LSR在claudin-low BRCA细胞系中的过表达恢复了与转化相关的基因的表达,
肿瘤发生和紧密的连接处,从而将这些细胞恢复为其他BRCA亚型。我们的飞行员数据显示
高LSR水平与碱性肿瘤,AA种族和饮食引起的肥胖症显着相关。我们的
初步数据还表明,膜定位的LSR介导脂质内吞作用,从而转移
细胞生物能学,而核LSR结合DNA,并且与患者死亡率显着相关
BRCA活检的飞行员。为了推进这些初步研究,我们提出了一种双重方法,其中包括
描述LSR在推动侵略性BRCA行为中的作用,并定义分子机制
乳房组织中的毒性摄取和促进注射。具体而言,我们的目的是(1)确定LSR-
在BRCA进展过程中探索的驱动途径和攻击性细胞行为的产生,(2)
定义BRCA细胞中LSR介导的脂质和毒性摄取的机制,并对结果对
癌症生物能和细胞生理学。我们的建议可能会阐明LSR作为生物学联系
肥胖,感染,癌症分布和BRCA生理学。从提议中获得的新知识
研究将为饮食对乳腺癌的影响的生物学基础提供重要的见解,可能
将LSR识别为一种新型的治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jodie Michelle Fleming其他文献
Jodie Michelle Fleming的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jodie Michelle Fleming', 18)}}的其他基金
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
- 批准号:
10204739 - 财政年份:2017
- 资助金额:
$ 30.14万 - 项目类别:
HGF signaling in African-American and Basal-like Breast Cancer
非裔美国人乳腺癌和基底样乳腺癌中的 HGF 信号传导
- 批准号:
8726349 - 财政年份:2013
- 资助金额:
$ 30.14万 - 项目类别:
HGF signaling in African-American and Basal-like Breast Cancer
非裔美国人乳腺癌和基底样乳腺癌中的 HGF 信号传导
- 批准号:
8491064 - 财政年份:2013
- 资助金额:
$ 30.14万 - 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
- 批准号:
8337127 - 财政年份:2012
- 资助金额:
$ 30.14万 - 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
- 批准号:
8731643 - 财政年份:2012
- 资助金额:
$ 30.14万 - 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
- 批准号:
8551659 - 财政年份:2012
- 资助金额:
$ 30.14万 - 项目类别:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为
- 批准号:
9050348 - 财政年份:2010
- 资助金额:
$ 30.14万 - 项目类别:
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
- 批准号:
9750532 - 财政年份:
- 资助金额:
$ 30.14万 - 项目类别:
Full Project 4: Molecular Pathways to Breast Cancer Mortality among African American and White Women
完整项目 4:非裔美国和白人女性乳腺癌死亡率的分子途径
- 批准号:
10004337 - 财政年份:
- 资助金额:
$ 30.14万 - 项目类别:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为
- 批准号:
9152333 - 财政年份:
- 资助金额:
$ 30.14万 - 项目类别:
相似海外基金
Mitigating the Effects of Structural Racism on Chronic Kidney Disease Disparities among African Americans
减轻结构性种族主义对非裔美国人慢性肾病差异的影响
- 批准号:
10742680 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别:
Transcriptome and spatial analyses of tumor environment in addressing colorectal cancer racial and ethnical disparities
肿瘤环境的转录组和空间分析在解决结直肠癌种族和民族差异方面的作用
- 批准号:
10743201 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别:
Investigating mitochondrial dysfunction in high-risk prostate cancer
研究高危前列腺癌中的线粒体功能障碍
- 批准号:
10570345 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别:
Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.
解码肿瘤代谢和免疫相互作用导致非裔美国膀胱癌患者的种族差异。
- 批准号:
10718787 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别:
Health Equity in Emergency Trauma Care: Analysis of disparities in the pre-hospital emergency trauma care system
紧急创伤护理中的健康公平:院前紧急创伤护理系统的差异分析
- 批准号:
10594244 - 财政年份:2023
- 资助金额:
$ 30.14万 - 项目类别: